Nuwellis (NASDAQ:NUWE) Releases Quarterly Earnings Results

Nuwellis (NASDAQ:NUWE) announced its quarterly earnings data on Wednesday. The company reported $0.56 earnings per share (EPS) for the quarter, Zacks reports. Nuwellis had a negative return on equity of 1,424.01% and a negative net margin of 176.45%.

Nuwellis Price Performance

Shares of NASDAQ NUWE traded down $0.14 during mid-day trading on Wednesday, hitting $2.64. The company had a trading volume of 55,629 shares, compared to its average volume of 359,367. Nuwellis has a 12 month low of $2.60 and a 12 month high of $83.16. The firm has a market cap of $2.38 million, a P/E ratio of -0.07 and a beta of 0.06. The business’s 50-day simple moving average is $3.57 and its 200-day simple moving average is $13.22.

Wall Street Analyst Weigh In

Several research firms have recently commented on NUWE. Weiss Ratings reissued a “sell (e+)” rating on shares of Nuwellis in a research report on Tuesday. Wall Street Zen raised shares of Nuwellis to a “hold” rating in a research report on Friday, July 18th. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold”.

About Nuwellis

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.